Clinical Trial Update: Safety and Efficacy of Nabilone in Alzheimer's Disease [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on nabilone for Alzheimer's disease evaluating safety and efficacy across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Agitation
• Alzheimer Disease
• Obesity
• Oxidative Stress
• Pain

Drugs mentioned

• Nabilone (nabilone)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Alzheimer Disease, Agitation | Phase 2, Phase 3 | Status: COMPLETED